To be, or not to be

Catch Hamlet at the Millennium Forum on Thursday 26th & Friday 27th January

Which play is considered to be Shakespeare's finest work?

It’s a question that draws debate even from the most dedicated of Shakespeare’s followers, but one thing’s for sure, Hamlet is up there. Originally published in 1603, the ‘Tragedy of Hamlet’, which is often shortened simply to Hamlet, is Shakespeare's longest play and is ranked among the most powerful and influential tragedies in English literature.

The King of Denmark is dead. Consumed with grief, Prince Hamlet avenges his father’s death with devastating consequences for his family and the Kingdom. The spirit of a murdered king, the wrath of a vengeful son, and the turmoil of Denmark in 1601. Shakespeare’s most iconic and challenging play tells the tale of young Prince Hamlet fighting the new King who stole his throne.

Later this month Icarus Theatre Collective will bring Hamlet to the Millennium Forum for what is being billed as ‘Shakespeare for the Game of Thrones generation’ and a ‘sexy, bloody production and fast-paced’ and not to mention the fact it contains arguably the most iconic line in theatre; "To be, or not to be, that is the question." Hamlet may have been Shakespeare's longest play, but this production has been cut to a sensible 2 hour and 30 minutes.

Icarus are a company of seasoned classical actors who embrace the brutality of the greatest play ever written. A gripping, ensemble style brings exhilaration and violence to the unforgettable music and delicacy of the words.

Blending traditional and physical theatre with a musical score, this muscular production brings vividly to life some of literature’s most vibrant language and characters in a way you’ve never seen before: bold, exciting, action-packed.

Hamlet performs at the Millennium Forum on Thursday 26th and Friday 27th January, with tickets available from the Millennium Forum Box Office. Telephone 71 264455 / www.millenniumforum.co.uk. Photos by Jack Ladenburg.

 

Features

Signup for our mailing list

Follow Us: